Circular RNAs modulate cancer drug resistance: advances and challenges
Exosomal miR-92b-5p regulates N4BP1 to enhance PTEN mono-ubiquitination in doxorubicin-resistant AML
Research advances in natural sesquiterpene lactones: overcoming cancer drug resistance through modulation of key signaling pathways
Unraveling <i>BRAF</i> alterations: molecular insights to circumvent therapeutic resistance across cancer types
The epigenetic mechanisms involved in the treatment resistance of glioblastoma
Antibody-drug conjugates in breast cancer treatment: resistance mechanisms and the role of therapeutic sequencing
Sophisticated roles of tumor microenvironment in resistance to immune checkpoint blockade therapy in hepatocellular carcinoma
Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approaches
Exploring YAP1-related TIME in SCLC: implications for survival and treatment response to immuno-chemotherapy
Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance
Histone deacetylases in the regulation of cell death and survival mechanisms in resistant BRAF-mutant cancers
Optimizing therapeutic approaches for HR+/HER2- advanced breast cancer: clinical perspectives on biomarkers and treatment strategies post-CDK4/6 inhibitor progression
Regulatory role of non-coding RNAs in 5-Fluorouracil resistance in gastrointestinal cancers
Integrative multi-omics analysis for identifying novel therapeutic targets and predicting immunotherapy efficacy in lung adenocarcinoma
Cancer-associated fibroblast-derived extracellular vesicles: regulators and therapeutic targets in the tumor microenvironment
Ferroptosis-related signaling pathways in cancer drug resistance
Strategies to combat cancer drug resistance: focus on copper metabolism and cuproptosis